Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in agingShow others and affiliations
2023 (English)In: Neurobiology of Aging, ISSN 0197-4580, E-ISSN 1558-1497, Vol. 126, p. 103-112Article in journal (Refereed) Published
Abstract [en]
Apolipoprotein E (APOE) ε4, the strongest genetic risk factor for late onset Alzheimer's disease (LOAD), has been associated with cognitive decline independent from AD pathology, but the role for other LOAD risk genes in normal cognitive aging is less studied. We examined the effect of APOE ε4 and several different polygenic risk scores (PRS) for LOAD on cognitive level and decline in aging, using longitudinal data from the UK Biobank. While PRS-LOAD including all variants (except APOE) predicted cognitive level, APOE ε4 and PRS-LOAD based on 17 non-APOE gene variants with strong association to AD (p < 5e-8) predicted age-related decline in verbal numeric reasoning. The effect on decline were partly driven by 4 variants involved in the immune system. Those variants also predicted serum levels of the inflammatory marker C-reactive protein (CRP), but CRP did not mediate the effect on decline. Those findings suggest genetic variations in immune functions play a role in aspects of cognitive aging that may be independent of LOAD pathology as well as systemic inflammation measured by CRP.
Place, publisher, year, edition, pages
Elsevier, 2023. Vol. 126, p. 103-112
Keywords [en]
Alzheimer's disease, APOE, Cognitive aging, Pathway-based PRS-LOAD, Polygenic risk scores, Serum CRP
National Category
Geriatrics
Identifiers
URN: urn:nbn:se:umu:diva-206355DOI: 10.1016/j.neurobiolaging.2023.02.006ISI: 000961467100001PubMedID: 36965205Scopus ID: 2-s2.0-85150886818OAI: oai:DiVA.org:umu-206355DiVA, id: diva2:1753264
Funder
Swedish Research Council, 2018-05973Swedish Research Council, 2015-03255Swedish Research Council, 2019- 01272Swedish Research Council, 2020-06101The Karolinska Institutet's Research FoundationKonung Gustaf V:s och Drottning Victorias FrimurarestiftelseSwedish Research Council, 2017-03011The Karolinska Institutet's Research Foundation, 2020-022602023-04-262023-04-262023-04-26Bibliographically approved